Identification of genes regulated by UV/salicylic acid

International Journal of Radiation Biology

Volumn 76, Issue 2, 2000, Pages 189-198

  Paunesku, T ^a   Chang Liu, C M ^a   Shearin Jones, P ^a   Watson, C ^a   Milton, J ^a   Oryhon, J ^a   Salbego, D ^b   Milosavljevic, A ^a   Woloschak, G E ^a  

^a Biosciences Division   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CISPLATIN; COMPLEMENTARY DNA; ELONGATION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; LACTATE DEHYDROGENASE; PROTEIN; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SALICYLIC ACID; TRANSCRIPTION FACTOR; VINBLASTINE;

APOPTOSIS; ARTICLE; BINDING SITE; CELL SURVIVAL; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET IRRADIATION;

EID: 0033976356     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530000138844     Document Type: Article

References (54)

1. Adams, M. D., Dubnick, M., Kerlavage, A. R., Moreno, R., Kelley, J. M., Utterback, T. R., Nagle, J. W., Fields, C. And Venter, J. C., 1992, Sequence identification of 2,375 human brain genes. Nature, 355, 632-634.
2. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J., 1990, Basic local alignment search tool. Journal of Molecular Biology, 215, 403-410.
3. Baeuerle, P. A. and Baltimore, D., 1988a, IκB: a specific inhibitor of the NF-κB transcription factor. Science, 242, 540-546.
4. Baeuerle, P. A. and Baltimore, D., 1988b, Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell, 53, 211-217.
5. Baeuerle, P. A. and Baltimore, D., 1996, NF-κB: ten years after. Cell, 87, 13-20.
6. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K. and Siebenlist, U., 1993, The oncoprotein BCL-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell, 72, 729-739.
7. Chang, C.-C., Zhang, J., Lombardi, L., Neri, A. And Dalla-Favera, R., 1994, Mechanism of expression and role in transcriptional control of the proto-oncogene NF-κB/ LYT-10. Oncogene, 9, 923-933.
8. Chen, H., Crabb, J. W. and Kinsey, J. A., 1998, The neurospora aab-1 gene encodes a CCAAT binding protein homologous to yeast HAP5. Genetics, 148, 123-130.
9. Ciana, P., Neri, A., Cappellini, C., Cavallo, F., Pomati, M., Chang, C.-C., Maiolo, A. T. and Lombardi, L., 1997, Constitutive expression of lymphoma-associated NF-κB-2/Lyt-10 proteins is tumoregenic in murine fibroblasts. Oncogene, 14, 1805-1810.
10. Dejardin, E., Bonizzo, G., Bellahcene, A., Castronovo, V., Merville, M. P. and Bours, V., 1995, Highly-expressed p100/p52 (NF-κB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene, 11, 1835-1841.
11. De Wit, H., Dokter, W. H., Koopmans, S. B., Lummen, C., Van Der Leij, M., Smit, J. W. and Vellenga, E., 1998, Regulation of p100 (NFκB) expression in human monocytes in response to inflammatory mediators and lymphokines. Leukemia, 12, 363-370.
12. Dileonardo, A., Linke, S. P., Clarkin, K. and Wahl, G. M., 1994, DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cipl in normal human fibroblasts. Genes and Development, 8, 2540-2551.
13. Eguchi, Y., Shimizu, S. and Tsujimoto, Y., 1997, Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Research, 57, 1835-1840.
14. Frantz, B. and O'Neill, E. A., 1995, The effect of sodium salicylate and aspirin on NF-κB. Science, 270, 2017-2019.
15. Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K. and Siebenlist, U., 1992, The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature, 359, 339-342.
16. Ghosh, S. and Kopp, E., 1995, Reply to Frantz and O'Neill. Science, 270, 2018-2019.
17. Grilli, M., Pizzi, M., Memo, M. and Spano, P., 1996, Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science, 274, 1383-1385.
18. Grotzinger, T., Jensen, K. and Will, H., 1996, The Interferon (IFN)-stimulated gene Sp 100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type 1 IFN inducibility. Journal of Biological Chemistry, 271, 25 253-25 260.
19. Hansen, S. K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P. A. and Blasi, F., 1992, A novel complex between the p65 subunit of NF-κB and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO Journal, 11, 205-213.
20. Hassinen, I. E., Vuorinen, K. H., Ylitalo, K. and Alarami, A., 1998, Role of cellular energetics in ischemia-reperfusion and ischemic preconditioning of myocardium. Molecular and Cellular Biochemistry, 184, 393-400.
21. Hattori, N., Suzuki, H., Wang, Y., Minoshima, S., Shimizu, N., Yoshino, H., Kurashima, R., Tanaka, M., Ozawa, T. and Mizuno, Y., 1995, Structural organization and chromosomal localization of the human nuclear gene (NDUFV2) for the 24-kDa iron-sulfar subunit of complex I in mitochondrial respiratory chain. Biochemical Biophysical Research Communications, 216, 771-777.
22. Kopp, E. and Ghosh, S., 1994, Inhibition of NF-κB by sodium salicylate and aspirin. Science (Washington DC), 265, 956-959.
23. Lane, D. P., 1992, p53, guardian of the genome. Nature, 358, 15-16.
24. Lane, D. P., 1993, A death in the life of p53. Nature, 362, 786-787.
25. Lebowitz, M. S. and Pedersen, P. L., 1993, Regulation of the mitochondrial ATP synthase/ATPase complex: cDNA cloning, sequence, overexpression, and secondary structural characterization of a functional protein inhibitor. Archives of Biochemistry and Biophysics, 301, 64-70.
26. Liang, P., Averboukh, L. and Pardee, A. B., 1993, Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Research, 21, 3269-3275.
27. Liou, H. C. and Baltimore, D., 1993, Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Current Opinions in Cellular Biology, 5, 477-487.
28. Lombardi, L., Ciana, P., Cappellini, C., Trecca, D., Guerrini, L., Migliazza, A., Maiolo, A. T. and Neri, A., 1995, Structural and functional characterization of the promoter regions of the NF-κB gene. Nucleic Acids Research, 23, 2328-2336.
29. Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J. and Baldwin, A. S., jr, 1997, Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic ras. Science, 278, 1812-1815.
30. McNabb, D. S., Xing, Y. and Guarente, L., 1995, Cloning of yeast HAP5: a novel subunit of a heterotrimeric complex required for CCAAT binding. Genes and Development, 9, 47-58.
31. Mercurio, F., Didonato, J. A., Rosette, C. and Karin, M., 1993, p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes and Development, 7, 705-718.
32. Methot, N., Pickett, G., Keene, J. D. and Sonenberg, N., 1996, In vitro RNA selection identifies RNA ligands that specifically bind to eukaryotic translation initiation factor 4B: the role of the RNA remotif. RNA, 2, 38-50.
33. Migliazza, A., Lombardi, L., Rocchi, M., Trecca, D., Chang, C.-C., Antonacci, R., Fracchiolla, N. S., Ciana, P., Maiolo, A. T. and Neri, A., 1994, Heterogeneous chromosomal aberrations generate 3′ truncations of the NF-κB2/lyt-10 gene in lymphoid malignancies. Blood, 84, 3850-3860.
34. Milburn, S. C., Hershey, J. W., Davies, M. V., Kelleher, K. and Kaufman, R. J., 1990, Cloning and expression of eukaryotic initiation factor 4B cDNA: sequence determination identifies a common RNA recognition motif. EMBO Journal, 9, 2783-2790.
35. Milosavljevic, A., Zeremski, M., Strezoska, Z., Grujic D., Dyanov, H., Batus, S., Salbego, D., Paunesku, T., Soares, M. B. and Crkvenjakov, R., 1996, Discovering distinct genes represented in 29,570 clones from infant brain cDNA libraries by applying sequencing by hybridization methodology. Genome Research, 6, 132-141.
36. Morley, S. J. and Traugh, J. A,, 1993, Stimulation of translation in 3T3-L1 cells in response to insulin and phorbol ester is directly correlated with increased phosphate labelling of initiation factor (eIF-) 4F and ribosomal protein S6. Biochimie, 75, 985-989.
37. Muller, S. and Dejean, A., 1999, Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. Journal of Virology, 73, 5139-5143.
38. Pogliaghi, G., Tacchini, L., Anzon, E., Radice, L, and Bernelli-Zazzera, A., 1995, Heat shock activation of NF-κB in rat liver is mediated by interleukin-1. FEBS Letters, 372, 181-184.
39. Rosette, C. and Karin, M., 1996, Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science, 274, 1194-1197.
40. Royds, J. A., Dower, S. K., Qwarnstrom, E. E. and Lewis, C. E., 1998, Response of tumour cells to hypoxia: role of p53 and NF-κB, Molecular Pathology, 51, 55-61.
41. Seeler, J. S., Marchio, A., Sitterlin, D., Transy, C. and Dejean, A., 1998, Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proceedings of the National Academy of Sciences of the United States of America, 95, 7316-7321.
42. Sternsdorf, T., Jensen, K., Reich, B. and Will, H., 1999, The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. Journal of Biological Chemistry, 274, 12 555-12 566.
43. Swingler, S., Morris, A. and Easton, A., 1994, Tumor necrosis factor α and interleukin-1β include specific sub units of NFκB to bind the HIV-1 enhancer: characterisation of transcription factors controlling human immunodeficiency virus type 1 gene expression in neural cells. Biochemical and Biophysical Research Communications, 203, 623-630.
44. Takeno, T. and Li, S. S., 1989, Structure of the human lactate dehydrogenase B gene. Biochemical Journal, 257, 921-924.
45. Ten, R. M., Paya, C. V., Israël, N., Le Bail, O., Mattei, M.-G., Virelizier, J.-L., Kourilsky, P. and Israël, A., 1992, The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO Journal, 11, 195-203.
46. Thakur, S., Lin, H. C., Tseng, W. T., Kumar, S., Bravo, R., Foss, F., Gélinas, C. and Rabson, A. B., 1994, Rearrangement and altered expression of the NF-κB-2 gene in human cutaneous T-lymphoma cells. Oncogene, 9, 2335-2344.
47. Valerie, K., Deleres, A., Bruck, C., Thiriart, C., Rosenberg, H., Debouch, C. and Rosenberg, M., 1988, Activation of human immunodeficiency virus type I by DNA damage in human cells. Nature, 333, 78-81.
48. Vane, J. R., 1971, Inhibition of prostaglandin synthesis as a mechanism of action of the aspirin-like drugs. Nature New Biology, 231, 232-235.
49. Vane, J., 1994, Towards a better aspirin. Nature, 367, 215-216.
50. Woloschak, G. E., Panozzo, J., Schreck, S. and Libertin, C. R., 1995a, Salicylic acid inhibits ultraviolet-and cis-platinum-induced human immunodeficiency virus expression. Cancer Research, 55, 1696-1700.
51. Woloschak, G. E., Paunesku, T., Chang-Liu, C.-M. and Grdina, D. J., 19951b, Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Research, 55, 4788-4792.
52. Woloschak, G. E., Schreck, S., Panozzo, J., Chang-Liu, C.-M. and Libertin, C., 1997, HIV expression is indured in dying cells. Biochimica et Biophysica Acta, 1351, 105-110.
53. Wolthuis, R. M., Cremers, A. F., Kasperaitis, M. A., Van Der Mast, C., Voorma, H. O. and Boonstra, J., 1993, Epidermal growth factor stimulates phosphorylation of eukaryotic initiation factor 4B, independently of protein kinase C. Biochemical Biophysical Acta, 1177, 160-166.
54. Yin, M.-J., Yamamoto, Y. and Gaynor, R. B., 1998, The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature, 396, 77-80.